Genelux (GNLX) Interest & Investment Income (2023 - 2026)
Genelux's (GNLX) quarterly Interest & Investment Income came in at $173000.0 in Q1 2026, down 5.98% year-on-year from $184000.0 in Q1 2025, and up 35.16% quarter-over-quarter from $128000.0 in Q4 2025.
Genelux (GNLX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Genelux's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $173000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 5.98% year-over-year to $173000.0 in Q1 2026; TTM through Mar 2026 was $700000.0, a 9.09% decrease from a year earlier, with the FY2025 full-year figure at $711000.0, up 1.57% from the prior year.
- Interest & Investment Income grew to $173000.0 in Q1 2026 per GNLX's latest filing, from $128000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $265000.0 in Q1 2024 and bottomed at $4000.0 in Q3 2023.
- The 4-year median for Interest & Investment Income is $184000.0 (2025), against an average of $179909.1.
- Across the five-year window, Interest & Investment Income soared 5450.0% in 2024 and tumbled 36.32% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $240000.0 in 2023, then fell by 16.25% to $201000.0 in 2024, then tumbled by 36.32% to $128000.0 in 2025, then soared by 35.16% to $173000.0 in 2026.
- Per Business Quant, the three latest GNLX Interest & Investment Income figures stand at $173000.0 (Q1 2026), $128000.0 (Q4 2025), and $175000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 173,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 128,000.00 |
| Sep 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 222,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 240,000.00 |
| Sep 30, 2023 | 4,000.00 |